Translational Development Acquisition Corp. (TDAC)
NASDAQ: TDAC · Real-Time Price · USD
Translational Development Acquisition currently trades with the ticker symbol TDACU
14.08
-0.67 (-4.55%)
Oct 31, 2021, 11:00 PM EST - Market closed

Company Description

Translational Development Acquisition Corp. intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.

The company was incorporated in 2022 and is based in New York, New York.

Translational Development Acquisition Corp.
Translational Development Acquisition logo
Country United States
Founded 2022
IPO Date Dec 23, 2024
Industry Shell Companies
Sector Financials
CEO Michael M. Hoffman

Contact Details

Address:
52 E. 83rd Street
New York, New York 10028
United States
Phone 917 979 3072
Website translational-development.com

Stock Details

Ticker Symbol TDAC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $10.00
CIK Code 0001926599
CUSIP Number 89615T106
ISIN Number US89615T1060
SIC Code 6770

Key Executives

Name Position
Michael B. Hoffman Chief Executive Officer, Director
Avanindra C. Das Chief Financial Officer
John M. Glazer Director Nominee
E. Premkumar Reddy Director Nominee
Curtis T. Keith Director Nominee
Maria L. Maccecchini Director Nominee
Susan P. Kennedy Director Nominee

Latest SEC Filings

Date Type Title
Dec 31, 2024 8-K Current Report
Dec 27, 2024 8-K Current Report
Dec 23, 2024 424B4 Prospectus
Dec 20, 2024 EFFECT Notice of Effectiveness
Dec 20, 2024 CERT Certification by an exchange approving securities for listing
Dec 19, 2024 8-A12B Registration of securities
Dec 19, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Nov 20, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Nov 5, 2024 UPLOAD Filing
Oct 22, 2024 S-1 General form for registration of securities under the Securities Act of 1933